Skip to main content
. 2021 Oct 6;13(10):1631. doi: 10.3390/pharmaceutics13101631

Table 1.

Clinical characteristics of the patients.

Patient Sex Age Type Tumor AFP Log10 AFP Partially Encapsulated (0/1) Satellite Nodule (0/1) Vascular Invasion (0/1) Differentiation (1/2/3) 1 Macrotrabecular (0/1) Aggressiveness 2 Aggression Class
1 F 48.5 Hepatocellular adenoma 1.6 0 0 0 0 0 0 0 Null
2 M 65.3 Necrotic lymph node 2.6 0 0 0 0 0 0 0 Null
3 F 53.5 Angiomyolipoma 4.9 0 0 0 0 0 0 0 Null
4 M 56.5 Microtrabecular and pseudoglandular, Nuclear grade 2 7.7 0 1 0 0 2 0 3 Moderate
5 F 47.4 Microtrabecular 1010 3 1 1 0 2 0 7 High
6 F 59.9 Trabecular, Edmondson grade 2, nuclear grade 2 28,000 4 1 0 0 2 0 7 High
7 M 76.4 Microtrabecular and pseudoglandular 6662 3 1 0 0 2 1 7 High
8 M 47.1 Macro-trabecular, Edmonson grade 3, nuclear grade 3 6 0 1 1 1 2 1 6 High
9 M 73.4 Edmondson grade 3, nuclear grade 3 1.4 0 1 0 0 2 1 4 Moderate
10 M 67.3 Edmonson grade 2, nuclear grade 2 6.4 0 1 0 0 2 0 3 Moderate
11 M 57.5 Macrotrabecular 5.1 0 1 1 1 2 1 6 High
12 M 69.3 Trabecular, Edmonson grade 2, nuclear grade 2 343 2 1 0 2 2 0 6 High
13 M 68.7 Edmonson grade 2 HCC, nuclear grade 2 2.5 0 1 0 2 2 0 3 Moderate
14 M 78.8 Trabecular 341 2 0 0 2 2 0 5 Moderate

1 Well differentiated HCC = 1, moderately differentiated HCC = 2, undifferentiated HCC = 3. 2 Sum of Log10 AFP, partially encapsulated, satellite nodule, vascular invasion, differentiation, macrotabecular HCC (min = 0, max: 7).